-+ 0.00%
-+ 0.00%
-+ 0.00%

VivoSim Labs partners with Chemveda to test AI-designed drug candidates in human tissue models

PUBT·11/03/2026 13:07:39
Listen to the news
VivoSim Labs partners with Chemveda to test AI-designed drug candidates in human tissue models
  • VivoSim Labs entered a strategic collaboration with Chemveda Life Sciences to screen AI-designed drug candidates using human tissue models.
  • Chemveda will develop compounds for pharmaceutical and biotechnology clients; testing will use human liver and intestine models.
  • The joint offering will serve Chemveda's global clients, with initial programs expected in Q4 2026.
  • Screening can evaluate more than 20 compounds in two weeks, providing early toxicity and efficacy feedback to guide molecular design.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VivoSim Labs Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030805PRIMZONEFULLFEED9868829) on November 03, 2026, and is solely responsible for the information contained therein.